Genelux Corporation (GNLX)

NASDAQ: GNLX · IEX Real-Time Price · USD
6.22
+0.20 (3.34%)
Mar 28, 2024, 9:38 AM EDT - Market open

Total Valuation

Genelux has a market cap or net worth of $160.31 million. The enterprise value is $131.77 million.

Market Cap 160.31M
Enterprise Value 131.77M

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, after market close.

Earnings Date May 2, 2024
Ex-Dividend Date n/a

Share Statistics

Genelux has 26.66 million shares outstanding. The number of shares has increased by 160.18% in one year.

Shares Outstanding 26.66M
Shares Change (YoY) +160.18%
Shares Change (QoQ) +4.55%
Owned by Insiders (%) 22.49%
Owned by Institutions (%) 21.84%
Float 20.18M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 673.56
Forward PS n/a
PB Ratio 6.67
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 553.64
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.56, with a Debt / Equity ratio of 0.06.

Current Ratio 3.56
Quick Ratio n/a
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -53.64

Financial Efficiency

Return on equity (ROE) is -758.80% and return on invested capital (ROIC) is -79.89%.

Return on Equity (ROE) -758.80%
Return on Assets (ROA) -117.00%
Return on Capital (ROIC) -79.89%
Revenue Per Employee $10,818
Profits Per Employee -$1.14M
Employee Count 22
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.16% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -80.16%
50-Day Moving Average 8.22
200-Day Moving Average 18.03
Relative Strength Index (RSI) 35.66
Average Volume (30 Days) 119,542

Short Selling Information

The latest short interest is 1.85 million, so 6.92% of the outstanding shares have been sold short.

Short Interest 1.85M
Short Previous Month 1.59M
Short % of Shares Out 6.92%
Short % of Float 9.14%
Short Ratio (days to cover) 9.20

Income Statement

In the last 12 months, Genelux had revenue of $238,000 and -$25.03 million in losses. Loss per share was -$1.34.

Revenue 238,000
Gross Profit 238,000
Operating Income -20.26M
Pretax Income -25.03M
Net Income -25.03M
EBITDA -23.92M
EBIT -24.57M
Loss Per Share -$1.34
Full Income Statement

Balance Sheet

The company has $29.87 million in cash and $1.33 million in debt, giving a net cash position of $28.54 million or $1.07 per share.

Cash & Cash Equivalents 29.87M
Total Debt 1.33M
Net Cash 28.54M
Net Cash Per Share $1.07
Equity / Book Value 24.03M
Book Value Per Share 0.90
Working Capital 22.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.88 million and capital expenditures -$782,000, giving a free cash flow of -$15.67 million.

Operating Cash Flow -14.88M
Capital Expenditures -782,000
Free Cash Flow -15.67M
FCF Per Share -$0.60
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -8,511.76% and -10,514.71%.

Gross Margin 100.00%
Operating Margin -8,511.76%
Pretax Margin -10,514.71%
Profit Margin -10,514.71%
EBITDA Margin -10,050.00%
EBIT Margin -10,322.27%
FCF Margin -6,581.93%

Dividends & Yields

Genelux does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -160.18%
Shareholder Yield -160.18%
Earnings Yield -15.61%
FCF Yield -9.77%

Analyst Forecast

The average price target for Genelux is $32.50, which is 422.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $32.50
Price Target Difference 422.42%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 64.13%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Genelux has an Altman Z-Score of -0.83 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.83
Piotroski F-Score 3